We recently reached a new milestone with the Human Cancer Models Initiative (HCMI) of the National Cancer Institute (NCI) by providing 215 advanced cancer models for worldwide cancer research. Over the past three years, ATCC has supported the HCMI by receiving, authenticating, manufacturing, and distributing the novel next-generation cancer models domestically and through our network of international distributors. A key element to the program is educating scientists about how to use these complex, and sometimes challenging, innovative models with a webinar and culture guides.